Nobilis Health Corp.
Other OTCTotal Valuation
Nobilis Health Corp. carries a market capitalization of 78.00, placing it among publicly traded companies globally. Its enterprise value stands at 256.95M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 78.00 |
| Enterprise Value | 256.95M |
Share Statistics
Nobilis Health Corp. currently has 78.25M shares outstanding.
| Shares Outstanding | 78.25M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Nobilis Health Corp. trades at a trailing price-to-earnings ratio of 57.00. The price-to-sales ratio is 0.33, and the price-to-book ratio stands at -1.20.
| PE Ratio | 57.00 |
| PS Ratio | 0.33 |
| PB Ratio | -1.20 |
| P/TBV Ratio | 8.55 |
| P/FCF Ratio | 6.74 |
| P/OCF Ratio | 8.66 |
Enterprise Valuation
On an enterprise value basis, Nobilis Health Corp. trades at an EV/EBITDA multiple of 6.56 and an EV/FCF ratio of 14.39. The EV/Sales ratio of 0.90 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 11.23 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.90 |
| EV / EBITDA | 6.56 |
| EV / EBIT | 11.23 |
| EV / FCF | 14.39 |
Financial Position
Nobilis Health Corp. maintains a current ratio of 2.21, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 73.60, indicating elevated leverage, while an interest coverage ratio of 4.10 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 2.21 |
| Quick Ratio | 1.99 |
| Debt / Equity | 73.60 |
| Debt / EBITDA | 3.56 |
| Interest Coverage | 4.10 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 0.45 |
| Return on Invested Capital (ROIC) | 3.20 |
| Return on Capital Employed (ROCE) | -1.42 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 32.68 |
Taxes
Over the trailing twelve months, Nobilis Health Corp. has paid 12.09M in income taxes, reflecting an effective tax rate of 60.70.
| Income Tax | 12.09M |
| Effective Tax Rate | 60.70 |
Income Statement
Over the trailing twelve months, Nobilis Health Corp. generated 285.10M in revenue and converted that into 1.64M in net income, yielding earnings per share of 0.10. EBITDA reached 39.18M, while operating income came in at 22.87M.
| Revenue | 285.10M |
| Gross Profit | 175.65M |
| Operating Income | 22.87M |
| Pretax Income | 19.92M |
| Net Income | 1.64M |
| EBITDA | 39.18M |
| EBIT | 22.87M |
| Earnings Per Share (EPS) | 0.10 |
Balance Sheet
Nobilis Health Corp. holds 16.53M in cash and equivalents against 139.63M in total debt, resulting in a net debt position of 108.81M. Total book value stands at -78.21M, with working capital of 97.47M providing operational flexibility.
| Cash & Cash Equivalents | 16.53M |
| Total Debt | 139.63M |
| Net Debt | 108.81M |
| Equity (Book Value) | -78.21M |
| Book Value Per Share | -1.00 |
| Working Capital | 97.47M |
Cash Flow
Nobilis Health Corp. produced 10.82M in operating cash flow over the past twelve months. After subtracting -3.28M in capital expenditures, free cash flow totaled 7.54M - equivalent to 0.10 per share.
| Operating Cash Flow | 10.82M |
| Capital Expenditures | -3.28M |
| Free Cash Flow | 7.54M |
| FCF Per Share | 0.10 |
Margins
Nobilis Health Corp. operates with a gross margin of 61.61, reflecting its pricing power and cost economics. The operating margin of 8.02 and net profit margin of 0.58 provide insight into operational efficiency.
| Gross Margin | 61.61 |
| Operating Margin | 8.02 |
| Pretax Margin | 6.99 |
| Profit Margin | 0.58 |
| EBITDA Margin | 13.74 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -36.17 |
| FCF Yield | 14.84 |
Scores
Nobilis Health Corp. posts an Altman Z-Score of 1.80, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.80 |